Your browser doesn't support javascript.
loading
Antimicrobial resistance at a crossroads: the cost of inaction.
Craig, Michael; Jernigan, Daniel; Laserson, Kayla; McBride, Stefanie; Fairbanks, Jessica; Sievert, Dawn; Armstrong, Paige A; Ewing Ogle, Heather; Zucker, Howard.
Afiliação
  • Craig M; Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA 30333, USA. Electronic address: bez7@cdc.gov.
  • Jernigan D; Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA 30333, USA.
  • Laserson K; CDC Global Health Center, Atlanta, GA, USA.
  • McBride S; Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA 30333, USA.
  • Fairbanks J; CDC Global Health Center, Atlanta, GA, USA.
  • Sievert D; Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA 30333, USA.
  • Armstrong PA; Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA 30333, USA.
  • Ewing Ogle H; Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA 30333, USA.
  • Zucker H; CDC Immediate Office of the Director, Atlanta, GA, USA.
Lancet ; 404(10458): 1083-1085, 2024 Sep 21.
Article em En | MEDLINE | ID: mdl-39265589

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2024 Tipo de documento: Article